Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mario Gabelli Adds to Activist Position in Rochester Medical Corporation

Mario Gabelli of Gamco Investors has recently added to his activist position in Rochester Medical Corporation (NASDAQ:ROCM). In a recent 13D filing with the SEC, Gamco disclosed ownership of about 528,200 shares of the company, with the value of the stake amounting to some $10.5 million at the current price of Rochester Medical’s stock. This means that in comparison with the end of the previous quarter, Gamco added around 17,700 shares to its position in the company.

Mario Gabelli

The move in Rochester Medical is interesting, since during the past two quarters Gabelli’s hedge fund has been unloading shares of the company. However, the purchase of additional shares can be explained, since it comes amid the recent announcement that C.R. Bard, Inc. (NYSE:BCRwill buy the company for a little over $260 million. Rochester Medical will be acquired by C.R Bard at a price of $20 per share. At a current price of $19.92, most of the merger arbitrage opportunity has dried up.

Still it’s worth noting that Grt Capital Partners, Jim Simons’ Renaissance Technologies and Algert Coldiron Investors are also invested in the merger arb play alongside Mario Gabelli and Gamco Investors.

Recommended Reading:

Is Leap Wireless a Good Investment?

Mario Gabelli: iGo, Inc. (IGOI) & Pre-Merger Intermec Inc. (IN)

Mario Gabelli On Tesla Motors & Elon Musk

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!